Seeking Alpha

St. Jude Medical (STJ -3.5%) drops after the FDA orders a review of its Riata defibrillator...

St. Jude Medical (STJ -3.5%) drops after the FDA orders a review of its Riata defibrillator leads. The agency recommends patients who have defibrillators with Riata leads should have x-rays or other imaging scans to check for abnormalities in the insulation surrounding the lead. STJ recalled the leads back in Nov. 2011; FDA says routine imaging may detect previously unrecognized abnormalities.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs